BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 37840315)

  • 1. Heterocyclic compounds with different moieties: synthesis and evaluation of biological activities assisted with the computational study.
    Kısa D; Koç E; Baş Topcu KS; İmamoğlu R
    J Biomol Struct Dyn; 2023 Oct; ():1-10. PubMed ID: 37840315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyphenolic compounds: Synthesis, assessment of antimicrobial effect and enzymes inhibition against important medicinal enzymes with computational details.
    İmamoğlu R; Koç E; Kısa D
    Bioorg Med Chem Lett; 2022 Jun; 65():128722. PubMed ID: 35395370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in-vitro anti-inflammatory, anticholinesterase and antidiabetic evaluation: computational and kinetic assessment of succinimides cyano-acetate derivatives.
    Pervaiz A; Jan MS; Hassan Shah SM; Khan A; Zafar R; Ansari B; Shahid M; Hussain F; Ijaz Khan M; Zeb A; Mukarram Shah SM
    J Biomol Struct Dyn; 2022 May; ():1-14. PubMed ID: 35507043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of 1,3,5-Triaryl-2-Pyrazoline Derivatives as Potent Dual Inhibitors of Urease and α-Glucosidase Together with Their Cytotoxic, Molecular Modeling and Drug-Likeness Studies.
    Mehmood R; Sadiq A; Alsantali RI; Mughal EU; Alsharif MA; Naeem N; Javid A; Al-Rooqi MM; Chaudhry GE; Ahmed SA
    ACS Omega; 2022 Feb; 7(4):3775-3795. PubMed ID: 35128286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel triazole bridged quinoline-anthracene derivatives: synthesis, characterization, molecular docking, evaluation of electronic and enzyme inhibitory properties.
    Gümüş A; Sadeghian N; Sadeghi M; Taslimi P; Gümüş S
    J Biomol Struct Dyn; 2023 Nov; ():1-16. PubMed ID: 37982719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonic-Assisted Synthesis of Heterocyclic Curcumin Analogs as Antidiabetic, Antibacterial, and Antioxidant Agents Combined with in vitro and in silico Studies.
    Zelelew D; Endale M; Melaku Y; Geremew T; Eswaramoorthy R; Tufa LT; Choi Y; Lee J
    Adv Appl Bioinform Chem; 2023; 16():61-91. PubMed ID: 37533689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel (
    Riadi Y; Afzal O; Kumar S; Varadharajan V; Geesi MH
    J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38523573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure-activity relationship and molecular modelling simulations.
    Mughal EU; Sadiq A; Ayub M; Naeem N; Javid A; Sumrra SH; Zafar MN; Khan BA; Malik FP; Ahmed I
    J Biomol Struct Dyn; 2021 Oct; 39(16):6154-6167. PubMed ID: 32752941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies.
    Ahmad A; Ullah F; Sadiq A; Ayaz M; Rahim H; Rashid U; Ahmad S; Jan MS; Ullah R; Shahat AA; Mahmood HM
    Drug Des Devel Ther; 2019; 13():4185-4194. PubMed ID: 31849450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
    Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
    Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
    Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
    Babaee S; Chehardoli G; Akbarzadeh T; Zolfigol MA; Mahdavi M; Rastegari A; Homayouni Moghadam F; Najafi Z
    Chem Biodivers; 2021 Jun; 18(6):e2000924. PubMed ID: 33861892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel 1,2,4-triazole tethered β-hydroxy sulfides as bacterial tyrosinase inhibitors: synthesis and biophysical evaluation through
    Saeed S; Saif MJ; Zahoor AF; Tabassum H; Kamal S; Faisal S; Ashraf R; Khan SG; Nazeer U; Irfan A; Bhat MA
    RSC Adv; 2024 May; 14(22):15419-15430. PubMed ID: 38741974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, α-amylase and α-glucosidase inhibition and molecular docking studies of indazole derivatives.
    Nawaz M; Taha M; Qureshi F; Ullah N; Selvaraj M; Shahzad S; Chigurupati S; Abubshait SA; Ahmad T; Chinnam S; Hisaindee S
    J Biomol Struct Dyn; 2022; 40(21):10730-10740. PubMed ID: 34463216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of anticancer properties and inhibitory effects of some metabolic enzymes including acetylcholinesterase, butyrylcholinesterase, alpha-glycosidase of some compounds with molecular docking study.
    Türkan F; Taslimi P; Abdalrazaq SM; Aras A; Erden Y; Celebioglu HU; Tuzun B; Ağırtaş MS; Gülçin İ
    J Biomol Struct Dyn; 2021 Jul; 39(10):3693-3702. PubMed ID: 32406329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA protection, molecular docking, enzyme inhibition and enzyme kinetic studies of 1,5,9-epideoxyloganic acid isolated from
    Başar Y; Yenigün S; İpek Y; Behçet L; Gül F; Özen T; Demirtaş İ
    J Biomol Struct Dyn; 2023 Aug; ():1-14. PubMed ID: 37615429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation (antioxidant, antimicrobial, enzyme inhibition, and cytotoxic) and molecular docking study of hydroxy methoxy benzoin/benzil analogous.
    Yaylı N; Kılıç G; Kahriman N; Kanbolat Ş; Bozdeveci A; Alpay Karaoğlu Ş; Aliyazıcıoğlu R; Erdinç Sellitepe H; Selin Doğan İ; Aydın A; Tatar G
    Bioorg Chem; 2021 Oct; 115():105183. PubMed ID: 34339978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Biological Evaluation of Novel Heterocyclic Fluoroquinolone Citrate Conjugates as Potential Inhibitors of Topoisomerase IV: A Computational Molecular Modeling Study.
    Allaka TR; Katari NK; Jonnalagadda SB; Malkhed V; Anireddy JS
    Curr Drug Discov Technol; 2021; 18(6):e130921187682. PubMed ID: 33155923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2.
    Shaker AMM; Shahin MI; AboulMagd AM; Abdel Aleem SA; Abdel-Rahman HM; Abou El Ella DA
    Bioorg Chem; 2022 Dec; 129():106143. PubMed ID: 36191430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological, toxicological and molecular docking evaluations of isoxazoline-thiazolidine-2,4-dione analogues as new class of anti-hyperglycemic agents.
    Fettach S; Thari FZ; Hafidi Z; Karrouchi K; Bouathmany K; Cherrah Y; El Achouri M; Benbacer L; El Mzibri M; Sefrioui H; Bougrin K; Faouzi MEA
    J Biomol Struct Dyn; 2023 Feb; 41(3):1072-1084. PubMed ID: 34957934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.